Pharmafile Logo
Pharmafocus logo
Advanced Search

Astraveus expands leadership team ahead of Lakhesys launch

April 16, 2025
Manufacturing Services Astraveus, Corporate, appointment

Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, …

Appointment

Moderna authorised to upscale development of mRNA vaccines in UK

April 15, 2025
Manufacturing and Production Moderna, UK, UK government, Virology, mrna, vaccination

Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …

News

ProQR appoints new CFO and CMO to drive clinical-stage growth

April 15, 2025
Research and Development Corporate, ProQR, appointments, clinical development

ProQR Therapeutics announced two major leadership appointments to support its transition into the clinical development phase of its RNA editing …

Appointment

Survey suggests Britons with a disability are concerned over AI-integrated healthcare

April 14, 2025
Business Services, Consultancy, Medical Communications AI, Consultancy, Corporate, Pharmacy, nuom, survey

A survey conducted by nuom, a British healthcare consultancy, found a majority of UK adults with a disability are concerned …

News

Successful trial results announced for potential rare eye disease treatment

April 14, 2025
Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …

News

Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch

April 14, 2025
Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease

International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …

News
blood-1813410_960_720

First cohort dosed with potential treatment for Von Willebrand disease

April 11, 2025
Research and Development Haematology, Hemab Therapeutics, Richmond Pharma, Von Willebrand Disease, bleeding disorder

UK-based clinical trials company, Richmond Pharmacology, has completed the first stage of Velora Pioneer, a phase 1/2 clinical trial investigating …

News

Inbiome’s rapid diagnostic platform approved for EU use, cuts infection identification time to just five hours

April 11, 2025
Research and Development Diagnostics, EU, Inbiome

Dutch diagnostics firm Inbiome has received In Vitro Diagnostic Regulation (IVDR) certification from the EU for its Molecular Culture ID …

News

West Middlesex Hospital goes live with tech to reduce prescribing errors

April 10, 2025
Information Technology, Manufacturing and Production Dosium, NHS, Paediatrics, West Middlesex Hospital

Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce …

News

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025
Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …

Appointment

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

April 10, 2025
Research and Development Alzheimer's disease, Neurology, TauRx Pharmaceutics, research and development

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over …

News

Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer

April 9, 2025
Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology

The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …

News

Ipsen’s Iqirvo approved for use in NHS Scotland to treat rare liver disease

April 8, 2025
Research and Development R&D, Rare Diseases, Scottish Medicines Consortium, ipsen, primary biliary cholangitis (PBC)

The Scottish Medicines Consortium (SMC) has accepted the use of Ipsen’s Iqirvo (elafibranor) in NHS Scotland for the treatment of …

News

High Force Research appoints Nathalie Huther as chief commercial officer

April 8, 2025
Manufacturing and Production, Research and Development Corporate, High Force Research, cco, manufacturing and production

High Force Research has announced that it has appointed Nathalie Huther as its first chief commercial officer (CCO) following the …

Appointment

ELRIG appoints Del Trezise as chair

April 8, 2025
Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …

Appointment

Academy of Medical Sciences invests record £7.6m into early-career biomedical researchers

April 7, 2025
Research and Development Academy of Medical Sciences, British Heart Foundation, Corporate, Wellcome, biomedical research, funding

The Academy of Medical Sciences has awarded £7.6m to support 62 early-career biomedical researchers across the UK, marking the largest …

News

European consortium launches project to advance alpha-emitting radiotherapies

April 7, 2025
Research and Development Akiram Therapeutics, European Consortium, Oncology, PreTT, TetraKit Technologies, radiotherapy

A new European research initiative PRE-CISE has been launched with the aim of developing next-generation targeted alpha-therapies for cancer treatment. …

News

New hormonal treatment launched to help prevent miscarriage in early pregnancy

April 4, 2025
Research and Development Besins Healthcare, Reproductive health, hormonal therapy, miscarriage, pregnancy

A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that …

News

Mehiläinen acquires Regina Maria and MediGroup, and welcomes Hellman & Friedman as new shareholder

April 4, 2025
Business Services, Marketing Services CVC, Corporate, MediGroup, Mehilainen, Regina Maria, shareholders

Mehiläinen, a Finnish health and social care provider, has announced that it has agreed to acquire Regina Maria and MediGroup. …

News

Bristol Myers Squibb receives positive CHMP opinion for Opdivo treatment

April 4, 2025
Research and Development CHMP, Oncology, bristol myers squibb, immunotherapy, lung cancer, opdivo

Bristol Myers Squibb (BMS) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026